SEC Comment Letter for PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981) (CNSY) — Jan 16, 2008
PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981)
Date: Jan. 16, 2008 · CIK: 0001095981 · Accession: 0000000000-08-002775
AI Filing Summary & Sentiment
Reasoning
Letter
Mail Stop 6010 January 16, 2008 Christopher J. Calhoun Chief Executive Officer Cytori Therapeutics, Inc. 3020 Callan Road San Diego, California 92121 Via U S Mail and FAX [(858) 458-0994 ]
Re: Cytori Therapeutics, Inc. Form 10-K for the fiscal year ended December 31, 2006 File No. 0-32501
Dear Mr. Calhoun: We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments. S i n c e r e l y , M a r t i n F . J a m e s Senior Assistant Chief Accountant
Show Raw Text
Mail Stop 6010 January 16, 2008 Christopher J. Calhoun Chief Executive Officer Cytori Therapeutics, Inc. 3020 Callan Road San Diego, California 92121 Via U S Mail and FAX [(858) 458-0994 ] Re: Cytori Therapeutics, Inc. Form 10-K for the fiscal year ended December 31, 2006 File No. 0-32501 Dear Mr. Calhoun: We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments. S i n c e r e l y , M a r t i n F . J a m e s Senior Assistant Chief Accountant